compound semaglutide fda alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products The FDA Just Banned Compounded

Blood glucose improvements appear faster than weight changes

doi: 10.2337/diabetes.48.5.1026 88 ThorkildsenCNeveSLarsenBDMeierEPetersenJS

Request both hemoglobin and ferritin tests from your healthcare provider to ensure you're getting a complete picture

The Science Behind Absorption: Why Injections Win The biggest difference between oral and injectable GLP-1 medications is something called bioavailabilityhow much of the drug actually makes it into your bloodstream

Individuals with a personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Type 2 (MEN 2) should not take a GLP-1 agonist

Resources and References New England Journal of Medicine Once-Weekly Semaglutide in Adults with Overweight or Obesity Journal of the American Medical Association (JAMA) Semaglutide and Weight Management PubMed Central (PMC) Semaglutides Effects on HbA1c, Weight, and Cardiovascular Risk Disclaimer: This article is intended for licensed medical professionals